本页面由Tiger Trade Technology Pte. Ltd.提供服务

Denali Therapeutics Inc.

18.95
-0.5000-2.57%
盘后:18.950.00000.00%19:30 EDT
成交量:123.14万
成交额:2,347.22万
市值:30.29亿
市盈率:-6.68
高:19.62
开:19.33
低:18.90
收:19.45
52周最高:27.30
52周最低:13.75
股本:1.60亿
流通股本:1.51亿
量比:0.59
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
净资产收益率:-54.93%
总资产收益率:-29.15%
市净率:3.63
市盈率(LYR):-6.38

数据加载中...

2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/10

重要事件披露

Form 8-K - Current report
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities